FULCRUM THERAPEUTICS
3.6500
07-10月-24 10:11:14
15 分の遅延
株式
-0.1700
-4.45%
本日の幅
3.6200 - 3.7800
ISIN
N/A
ソース
NASDAQ
-
15 5 2023 07:05:00 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Appoints Alex C. Sapir Chief Executive Officer
15 5 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
08 5 2023 16:05:01 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 5 2023 18:06:50 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07 4 2023 17:00:00 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces CFO Resignation
05 4 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 3 2023 17:00:00 提供 Nasdaq GlobeNewswire
-
09 3 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
06 3 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces Clinical Hold on FTX-6058 in Sickle Cell Disease
24 2 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 2 2023 17:27:22 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics to Participate at the Upcoming SVB Securities Global Biopharma Conference
08 2 2023 17:00:00 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
17 1 2023 23:15:16 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces Proposed Public Offering of Common Stock
17 1 2023 16:01:00 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13 1 2023 17:00:00 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Provides Business Update and 2023 Outlook
04 1 2023 07:02:00 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces CEO Transition
04 1 2023 07:01:00 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 12 2022 17:20:59 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics to Participate at Upcoming 2022 BofA Securities Biotech SMID Cap Conference
01 12 2022 16:01:00 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11 11 2022 18:33:20 提供 Nasdaq GlobeNewswire